What does Black Hawk Acquisition Corp do?

Black Hawk Acquisition Corp is a public company in the Biological Products, (No Diagnostic Substances) industry. It is registered with the SEC under CIK 0002000775 and trades on NASDAQ under the ticker BKHAU.

Is Black Hawk Acquisition Corp profitable?

Black Hawk Acquisition Corp was profitable in FY2025, reporting net income of $1.33M. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Black Hawk Acquisition Corp made?

Black Hawk Acquisition Corp has filed 93 documents with the SEC since 2023. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Black Hawk Acquisition Corp

BKHAU NASDAQ CIK: 0002000775 Biological Products, (No Diagnostic Substances)

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 93 filings →

Form	Description	Date
8-K	8-K	Mar 17, 2026
10-K	10-K	Mar 6, 2026
S-4/A	S-4/A	Mar 5, 2026
NT 10-K	NT 10-K	Mar 2, 2026
8-K	8-K	Feb 19, 2026
8-K	8-K	Feb 3, 2026
S-4/A	S-4/A	Jan 26, 2026
S-4/A	S-4/A	Jan 23, 2026
DEL AM	DEL AM	Dec 29, 2025
S-4	S-4	Dec 23, 2025

Insider Transactions

View all →

Insider	Title	Type	Shares	Owns After	Date
Black Hawk Management LLC	—	Award / Grant	1,725,000	1,725,000	Apr 4, 2024

About This Profile

This page aggregates all publicly available SEC EDGAR data for Black Hawk Acquisition Corp. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Net Income: $1.33M (FY2025)
Total Assets: $23.88M (FY2025)
Operating Income: ($915.5K)

Full financials →

Details

CIK: 0002000775
Ticker: BKHAU
Exchange: NASDAQ
First Filing: 2023
Total Filings: 93

Biological Products, (No Diagnostic Substances) rankings →